Isabel Rubio, MD, PhD, Vall d’Hebron University Hospital, Barcelona, Spain, discusses the significance of the ESSO 43 congress in fostering innovation, education, and collaboration in cancer surgery. She highlights the importance of networking with specialists from various countries and notes the growing need for robust data to improve patient outcomes. Dr Rubio emphasizes that traditional clinical trials are evolving, and the surgical oncology community is expanding both in membership and participation at meetings. Despite differing specialties, the collective mission remains the same: to work together in the fight against cancer. This interview took place at the ESSO 43 congress in Antwerp, Belgium.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.